The Clinical and Regulatory Affairs team at Alcyone Therapeutics plays a critical role in overseeing the development and implementation of clinical trials for their innovative CNS therapies. This team ensures compliance with regulatory requirements, facilitates communication with health authorities, and provides scientific guidance throughout the clinical development process. By integrating clinical insights and regulatory expertise, they help drive the advancement of Alcyone’s gene therapy programs targeting severe neurological conditions.
View all